LOT INFORMATION. (a) POLYPEPTIDE will provide a copy of all information and records relating to the batch/lot (e.g., expected lot size, yield, manufacturing deviations or rework). (b) INTRABIOTICS will have the right to review and/or audit all batch records and test and release data prior to acceptance of the material. (c) Changes to manufacturing parameters or specifications that may impact the quality or integrity of the Product shall be subject to review and approval by the INTRABIOTICS QA/QC unit prior to shipment to INTRABIOTICS. [ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.
Appears in 4 contracts
Samples: Development Supply Agreement (Intrabiotics Pharmaceuticals Inc /De), Development Supply Agreement (Intrabiotics Pharmaceuticals Inc /De), Development Supply Agreement (Introbiotics Phamaceuticals Inc)